of cholera he's a professor at yale school of medicine in connecticut and he explained to us how this new generation of anti malaria drugs work. the vaccine that we're working on which is still pre-clinical it's an animal testing taken just takes advantage of a gene that we discovered about 10 years ago that's produced by the malaria parasite that acts to suppress the immune response to the parasite and so our vaccine takes advantage of this protein product called p.m.s. and by vaccinated against it the host can clear the infection on its own and we combine this vaccine in an engine with a new type of r. and a cold so amplifying our name in many ways it's a 2nd generation of the m.r.d. vaccines currently used for covert because it persists at the injection site for about 6 to 8 weeks so you can inject very small amounts it can print be produced much more quickly much lower cost $1.00 can make about a 1000000 human doses in a liter of synthetic cell free fluid so it would be potentially much easier to distribute much less expensive and it could be produced at sites around the world in

earlier i spoke to dr richard bukola a professor at yale school of medicine in connecticut he's also the developer of another new possible vaccine for malaria i asked him how the new or in a vaccines work against the disease. the vaccine that we're working on which is still pre-clinical it's an animal testing taken just takes advantage of a gene that we discovered about 10 years ago that's produced by the malaria parasite that acts to suppress the immune response to the parasite and so our vaccine takes advantage of this protein product called pm if and by vaccinated against it the host can clear the infection on its own and we combine this vaccine an engine with a new type of r.n.a. called self amplifying arni in many ways it's a 2nd generation of the m.r.d. vaccines currently used for covert because it persists at the injection site for about 6 to 8 weeks so you can inject a very small amounts it can print be produced much more quickly a much lower cost $1.00 can make about a 1000000 human doses in a liter of synthetic cell free fluid so it would be potentially much easier to distri

that was dr richard view college professor at yale school of medicine speaking to a short time ago. now here in germany authorities are switching gears in the fight against the pandemic after months of struggling to contain a severe 3rd wave of the virus titer national restrictions were put in place this weekend including a controversial overnight curfew i reporter kate brady was out in the capital berlin to see what it's like. it's saturday night in berlin friedrichs kind of strict with just minutes to go before the new curfew kicks in at 10 pm enough time to grab a quick beer all some late night food for the road. right of here was the clock strikes 10 many local shops begin to roll down the shots as minutes later police arrive to clear structureless from the square. according to federal rules repeated violators of the measures risk a hefty fine of up to 25000 euros for most tonight it's just a polite request to head home the restrictions on movement during the late hours have been met with mixed response and. it's annoying. he was the. last of. the day we accept it but we can comp

i'm now joined by dr richard a professor at yale school of medicine in connecticut he's also the developer of another new possible thanks gene for malaria dr thanks for joining us we have recently heard a lot about the are in a vaccines against covert 19 how did these new vaccines work against malaria including the one you've developed. thank you michael the vaccine that we are working on which is still pre-clinical it's an animal testing take its takes advantage of a gene that we discovered about 10 years ago that's produced by the malaria parasite that acts to suppress the immune response to the parasite and so our vaccine takes advantage of this protein product called pm if and by vaccinate against it the host can clear the infection on its own and we combine this vaccine in an engine with a new type of r.n.a. called self amplifying our name in many ways it's a 2nd generation of the m.r.d. vaccines currently used for covert because it persists at the injection site for about 6 to 8 weeks so you can inject a very small amounts it can print be produced much more quickly a much lower cost

earlier we spoke to dr richard professor at yale school of medicine in connecticut he explained to us how this new generation of. drugs work. the vaccine that we are working on which is still pre-clinical it's an animal testing taken to takes advantage of a gene that we discovered about 10 years ago that's produced by the malaria parasite that acts to suppress the immune response to the parasite and so our vaccine takes advantage of this protein product called pm if and by vaccinated against it the host can clear the infection on its own and we combine this vaccine an agenda with a new type of r.n.a. called self amplifying our name in many ways it's a 2nd generation of the m.r.d. vaccines currently used for covert because it persists at the injection site for about 6 to 8 weeks so you can inject a very small amounts it can pre be produced much more quickly at much lower cost $1.00 can make about a 1000000 human doses in a liter of synthetic cell free fluid so it would be potentially much easier to distribute much less expensive and it could be produced at sites around the world in a m

the poll caught the attention of a biologyist at yale's school of medicine she is launching a study on people with long covid, comparing responses before and after they get the vaccine to understand if it really helps. one theory is that pieces of the virus may hide in the body. >> the vaccine triggers the body to clear the inflammation. >> and long covid is driven by a hyperactive auto immune response, and the vaccine may reduce the responses. >> there's no good therapy for long covid, and the people have really debilitating symptoms. so, there's a lot of excitement about this study. >> i was terrified of getting the vaccine and i was terrified to not get it. >> reporter: she suffered diz dizziness and exhaustion. >> i was in my life ving room dancing and my partner was like, i have not seen you dance in a year. i forgot what it felt like to wake up and feel good and excited for the day and not feel defeated before you get out of bed. >> reporter: it sounds like somebody switched a light on. yeahenroll a w i felt, like, hundred people in the study and see if the relief lasts and they

earlier we spoke to dr richard kala he's a professor at the yale school of medicine in connecticut and he explained to us how this new generation of anti malaria drugs work the vaccine that we're working on which is still pre-clinical it's an animal testing taken just takes advantage of a gene that we discovered about 10 years ago that's produced by the malaria parasite that acts to suppress the immune response to the parasite and so our vaccine takes advantage of this protein product called p.m.s. and by vaccinate against it the host can clear the infection on its own and we combine this vaccine antigen with a new type of r.n.a. called self amplifying our new in many ways it's a 2nd generation of the m.r.d. vaccines currently used for covert because it persists at the injection site for about 6 to 8 weeks so you can inject a very small amounts it can pre be produced much more quickly much lower cost $1.00 can make about a 1000000 human doses in a leader of synthetic cell free fluid so it would be potentially much easier to distribute much less expensive and it could be produced at sit

at sites around the world in a military affected countries dr richard bucolic professor at yale school of medicine talking to you earlier a little bit of sports now in bundesliga football dortmund beat both bird to nail to keep their champions league hopes alive thanks to a pair of goals from early holland a major blunder by riddle of baku fed the ball straight to holland who needed no 2nd invitation to open the scoring it was the young norwegians 24th goal of the season and with dortmund a man down in the 2nd half holland netted his 25th the 2nd most in the league there was no stopping him as he barreled forward with only the keeper to be. now let's take a look at all the bonus legal results so far on match day 31 rb leipzig beach stood guard which means byron will win the title until at least the next matchday laver couzin defeated frankfurt minds upset by or dortmund down vote on berlin defeated bremen and freiburg share the spoils with hoffenheim on friday cologne start passouts berg and god bought vs bielefeld you see the results there and due to her to berlin's covert quarantine clash with s

medicine, abbvie may be able to help. >>> read before signing. i'm michael smerconish in philadelphia. yale school ofrey sonnenfield had a gathering with american business leaders recently. the focus was the debate about voter rights playing out in several states most notably in georgia and soon to be in texas. he invited 129 ceos and 90 calls in and represented diverse interest and the biggest names in business. according to "the new york times" the zoom call beganit